Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Filamin B (FLNB) is a large cytoskeletal actin-binding protein encoded by the FLNB gene on chromosome 3p14.3. It organizes actin filaments into orthogonal networks, anchoring them to cellular membranes and participating in scaffolding for transmembrane receptors. FLNB is essential for intracellular signaling, mechanotransduction, and the regulation of cell structure, shape, and motility, being particularly important in chondrocyte biology and bone development; mutations are a major cause of several congenital skeletal malformation syndromes. Beyond structural roles, FLNB also regulates transcription and alternative splicing, and its dysregulation has been linked to altered cell death, proliferation, and metastasis in cancer. Currently, FLNB is not a direct target of any approved drugs but is a relevant biomarker in clinical genetics for specific skeletal dysplasias.
Not applicable, as there are currently no drugs known to target FLNB directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Filamin B (FLNB).